DalsnaFinance › IPOs › PMV Pharmaceuticals › IPO
PMV Pharmaceuticals, Inc. completed its initial public offering on NASDAQ on September 25, 2020, pricing at $18.00 a share.
| Ticker | PMVP |
|---|---|
| Exchange | NASDAQ |
| Status | Completed |
| Listing date | September 25, 2020 |
| Offering price | $18.00 |
| Shares offered | 11,765,000 |
| Total raised | $212M |
PMV Pharmaceuticals, Inc. sold 11,765,000 shares at $18.00 each on NASDAQ. Multiplied out, that is $211.8 million in gross proceeds, the figure before underwriting discounts and offering expenses, and it agrees with the $212 million total recorded for the deal.
PMV Pharmaceuticals, Inc. — quote, profile and latest news →
Source: SEC EDGAR filings for PMV Pharmaceuticals, Inc.. This page is general information, not investment advice.